What Are the Risks of Long-Term Antibiotics for FD?
At a Glance
Long-term oral antibiotics can reduce inflammation in folliculitis decalvans but are not a guaranteed cure. Relapses are common, and prolonged use can cause diarrhea, drug interactions, liver problems, allergic reactions, and antibiotic resistance, so treatment requires dermatologist monitoring.
In this answer
4 sections
Oral antibiotics are commonly used to treat Quinquaud folliculitis decalvans (FD), a rare, chronic inflammatory scalp condition that causes permanent scarring hair loss. Because FD is an inflammatory condition—not just a simple infection—antibiotics are used both to fight bacteria and to reduce inflammation, helping to preserve your remaining hair follicles [1]. However, FD frequently relapses when medication is stopped, so dermatologists sometimes prescribe prolonged or repeated courses of antibiotics.
While these extended treatments can suppress active disease, they are not a guaranteed cure and carry significant risks, including gastrointestinal side effects, infections like C. difficile, and the development of antibiotic-resistant bacteria [2][3]. Furthermore, hair that has already been lost to scarring typically will not regrow.
The Relapse Challenge and Antibiotic Stewardship
The most commonly prescribed oral antibiotics for FD include tetracyclines (such as doxycycline or minocycline) and a combination of clindamycin and rifampicin [4][1]. While these medications often produce a favorable initial response, studies show that relapse is very common after discontinuation [2]. For example, in one small retrospective study of 28 patients, 80% experienced a relapse shortly after finishing a course of clindamycin and rifampicin [5].
To reduce the chance of recurrence, European (EADV) guidelines suggest that treatment extending beyond the complete clearing of visible symptoms may be considered for moderate-to-severe disease [1]. However, there is no universally accepted treatment duration. Antibiotic stewardship involves using the shortest effective course because unnecessary or prolonged antibiotic exposure increases the likelihood of adverse events and encourages the survival of resistant bacteria, making future flare-ups harder to treat [6][7]. You should never extend, taper, or restart your antibiotics without your dermatologist’s instruction.
Medication-Specific Risks and Precautions
Different medications require specific precautions and monitoring. Always have a pharmacist review all your medications and supplements to check for interactions.
- Tetracyclines (e.g., Doxycycline, Minocycline): These can make your skin highly sensitive to the sun. Doxycycline can irritate the esophagus, so it should be taken with a full glass of water while you remain upright for at least 30 minutes. Calcium, iron, and antacids can block its absorption. Minocycline can occasionally cause dizziness, vertigo, or changes in skin pigmentation.
- Clindamycin: This antibiotic carries a higher risk of causing a severe intestinal infection called Clostridioides difficile (C. diff), which leads to severe diarrhea [8].
- Rifampicin (Rifampin): This drug strongly interacts with many other medications, reducing their effectiveness [9]. It also harmlessly turns urine, sweat, and tears an orange-red color.
- Oral Isotretinoin: For mild or refractory disease, your doctor might suggest isotretinoin, a non-antibiotic medication [1]. It requires strict monitoring of liver tests and lipids, and has a very high risk of causing severe birth defects.
⚠️ Pregnancy and Contraception Warning
Several FD treatments require careful family planning. Tetracyclines are generally avoided during pregnancy. Rifampicin can reduce the effectiveness of hormonal birth control, meaning you may need a backup contraceptive method. Oral isotretinoin causes severe fetal harm and requires strict adherence to pregnancy prevention programs. Always tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding before starting or changing these medications.
The Role of Bacterial Cultures and Monitoring
If your FD is not responding to standard treatments, your doctor may swab the affected area for a bacterial culture [10]. Scalp cultures must be interpreted carefully, as bacteria can simply live on the skin (colonization) without actually driving the disease. However, in one study of 39 patients unresponsive to standard treatments, about 28% had a different type of bacteria (gram-negative) on their scalp [10]. A culture can help your doctor choose a more targeted, narrow-spectrum antibiotic (one that attacks fewer types of bacteria) if an active infection is present [11][12].
Depending on your prescribed drug and medical history, your doctor will order specific laboratory tests to monitor your liver function, kidneys, and blood counts [9]. This monitoring helps catch potential medication-related liver or bile-system problems early.
Urgent Symptoms: When to Contact Your Doctor
While on long-term antibiotics, contact your doctor or seek prompt medical assessment if you experience:
- Severe or watery diarrhea, especially with fever, abdominal pain, or dehydration. This can happen during treatment or for weeks after stopping (a potential sign of C. diff). Do not try to self-treat this diarrhea.
- Signs of an allergic reaction, such as widespread hives, swelling of the face or throat, or difficulty breathing (seek emergency care immediately) [8].
- Signs of liver or bile-system distress, including yellowing of the skin or eyes (jaundice), dark urine, or severe right-sided abdominal pain.
- Severe headache or visual changes while taking a tetracycline.
- Painful swallowing or chest pain after taking doxycycline.
Common questions in this guide
Why are oral antibiotics used for folliculitis decalvans if it is not just an infection?
What are the main risks of taking antibiotics for folliculitis decalvans long term?
How long should I take oral antibiotics for folliculitis decalvans?
How likely is folliculitis decalvans to return after antibiotics are stopped?
What warning signs should I report while taking FD antibiotics?
Why might my dermatologist order a scalp culture or blood tests?
Can I take folliculitis decalvans medicines during pregnancy or with hormonal birth control?
Related questions
Show more
Get notified when new evidence is published on Quinquaud folliculitis decalvans.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
Management of folliculitis decalvans: The EADV task force on hair diseases position statement.
Waśkiel-Burnat A, Starace M, Iorizzo M, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2025; (39(8)):1385-1394 doi:10.1111/jdv.20687.
PMID: 40230058 - 2
Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.
Al-Naesan I, Trafoier T, Krepper D, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.
PMID: 42750403 - 3
Comparative Safety and Attributable Healthcare Expenditures Following Inappropriate Versus Appropriate Outpatient Antibiotic Prescriptions Among Adults With Upper Respiratory Infections.
Butler AM, Brown DS, Newland JG, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (76(6)):986-995 doi:10.1093/cid/ciac879.
PMID: 36350187 - 4
Folliculitis decalvans: a multicentre review of 82 patients.
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.
PMID: 25682915 - 5
Oral isotretinoin as the most effective treatment in folliculitis decalvans: a retrospective comparison of different treatment regimens in 28 patients.
Tietze JK, Heppt MV, von Preußen A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1816-21 doi:10.1111/jdv.13052.
PMID: 25712452 - 6
Association of Adverse Events With Antibiotic Use in Hospitalized Patients.
Tamma PD, Avdic E, Li DX, et al.
JAMA internal medicine 2017; (177(9)):1308-1315 doi:10.1001/jamainternmed.2017.1938.
PMID: 28604925 - 7
Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians.
Lee RA, Centor RM, Humphrey LL, et al.
Annals of internal medicine 2021; (174(6)):822-827 doi:10.7326/M20-7355.
PMID: 33819054 - 8
Association of Inappropriate Outpatient Pediatric Antibiotic Prescriptions With Adverse Drug Events and Health Care Expenditures.
Butler AM, Brown DS, Durkin MJ, et al.
JAMA network open 2022; (5(5)):e2214153 doi:10.1001/jamanetworkopen.2022.14153.
PMID: 35616940 - 9
Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy.
Mahoney MV, Childs-Kean LM, Khan P, et al.
Current infectious disease reports 2021; (23(12)):24 doi:10.1007/s11908-021-00766-x.
PMID: 34776793 - 10
Gram-negative infections in patients with folliculitis decalvans: a subset of patients requiring alternative treatment.
Samrao A, Mirmirani P
Dermatology online journal 2020; (26(2)).
PMID: 32239885 - 11
Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study.
Lyakhovitsky A, Segal O, Galili E, et al.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2023; (21(12)):1469-1477 doi:10.1111/ddg.15202.
PMID: 37875786 - 12
Development of key quality indicators for appropriate antibiotic use in the Republic of Korea: results of a modified Delphi survey.
Kim B, Lee MJ, Park SY, et al.
Antimicrobial resistance and infection control 2021; (10(1)):48 doi:10.1186/s13756-021-00913-y.
PMID: 33676558
This page is for informational purposes only and does not constitute medical advice about your follicitis decalvans treatment. Do not stop, restart, or change an antibiotic without guidance from your dermatologist or pharmacist.